Age-Related Radiotherapy Utilization Patterns and Associated Survival by Surgical Approach in Stage I–III Breast Cancer
This retrospective study of over 1.4 million women with stage I–III breast cancer reveals that while postoperative radiotherapy is associated with significantly improved overall survival across all age groups, its utilization declines with advancing age due to factors like non-selection and patient refusal, underscoring the need for individualized treatment decisions beyond chronological age.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of the paper below. It is not written or endorsed by the authors. For technical accuracy, refer to the original paper. Read full disclaimer
Breast cancer treatment has long relied on a fundamental choice: removing the entire breast or removing only the tumor and surrounding tissue. For decades, doctors have known that removing just the tumor, followed by radiation therapy to kill any remaining microscopic cells, offers survival rates equal to removing the whole breast for many patients. Radiation is a standard part of this "breast-conserving" approach. It is also recommended for some patients who undergo a full mastectomy, particularly those with higher-risk features like cancer in the lymph nodes or positive surgical margins. While the medical community agrees on the power of radiation to prevent recurrence and save lives, a gap remains in understanding how these treatments are actually used in the real world, especially among older women. The question is not just whether radiation works, but whether it is being offered to the people who need it most, or if age itself is quietly becoming a barrier to receiving a life-saving treatment.
A team of researchers from Cornell University and the University of Arizona set out to examine this exact issue using a massive database of medical records. They looked at more than 1.4 million women in the United States who were diagnosed with stage I to III breast cancer between 2004 and 2021. By analyzing this vast collection of real-world data, they could track who received radiation after surgery, who did not, and how these choices affected how long the women lived. The study focused on two main groups: women who had breast-conserving surgery and women who had a mastectomy but were at high enough risk that they should have received radiation afterward. The researchers wanted to see if the benefits of radiation held true across all ages and to understand why some older patients were not getting the treatment they were recommended.
The results painted a clear picture of survival. Across every age group, women who received radiation after their surgery lived longer than those who did not. For women who had breast-conserving surgery, receiving radiation was associated with a significantly lower risk of death. The same pattern appeared for women who had a mastectomy and were at high risk; those who received post-mastectomy radiation lived longer than those who did not. This survival advantage was consistent from young adulthood all the way through the oldest age groups studied, including women over 75. The data showed that the benefit of radiation did not disappear as patients got older; the treatment continued to offer a protective effect against mortality regardless of the patient's age.
Despite these clear benefits, the study found that the use of radiation dropped sharply as patients got older. Among women under 65, the vast majority received radiation when it was indicated. However, for women aged 75 and older, the rate of receiving radiation fell significantly. In the group of women who had breast-conserving surgery, only about 59 percent of those aged 75 or older received radiation, compared to over 90 percent of younger women. The drop was even steeper for women who had a mastectomy and needed radiation; only about 42 percent of those aged 75 or older received it. The researchers dug into the medical records to find out why these treatments were being skipped. They found that the most common reasons were not medical contraindications, such as severe frailty or other health conditions that would make radiation dangerous. Instead, the records showed that the treatment was often simply not selected as part of the plan, or the patient refused it.
This disconnect between the proven survival benefits and the declining use of the treatment suggests that age alone is influencing medical decisions in ways that may not be supported by the evidence. The researchers noted that while there are specific, well-studied cases where older women with very low-risk cancer might safely skip radiation, the women in this study had a broader range of disease stages and risk factors. For these patients, the data indicates that skipping radiation is associated with a higher risk of death. The study suggests that the decline in treatment is likely driven by a combination of factors, including a patient's fear of side effects, the logistical burden of traveling for daily treatments, or a physician's hesitation to recommend it to an older patient. The records did not show that older patients were systematically excluded because they were too sick to tolerate the therapy; rather, the treatment was often omitted without a documented medical reason.
The authors conclude that a patient's chronological age should not be the sole factor in deciding whether to receive radiation therapy. The data supports the idea that older women can and do benefit from these treatments, just as younger women do. The study highlights the need for more personalized conversations between doctors and patients. Instead of assuming that an older patient will not tolerate or benefit from radiation, clinicians should weigh the specific survival benefits against the patient's individual health status and preferences. By understanding that the survival advantage of radiation persists across the lifespan, doctors can better guide their patients toward decisions that maximize their chances of long-term survival, ensuring that age does not become an invisible barrier to effective care.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.